Upload
feride
View
213
Download
0
Embed Size (px)
Citation preview
Accepted Manuscript
Concentration-dependent effect of melatonin on DSPC membrane
Ipek Sahin, Duygu Bilge, Nadide Kazanci, Feride Severcan
PII: S0022-2860(13)00749-7
DOI: http://dx.doi.org/10.1016/j.molstruc.2013.08.060
Reference: MOLSTR 19995
To appear in: Journal of Molecular Structure
Received Date: 17 July 2013
Revised Date: 29 August 2013
Accepted Date: 30 August 2013
Please cite this article as: I. Sahin, D. Bilge, N. Kazanci, F. Severcan, Concentration-dependent effect of melatonin
on DSPC membrane, Journal of Molecular Structure (2013), doi: http://dx.doi.org/10.1016/j.molstruc.2013.08.060
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers
we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and
review of the resulting proof before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
1
Concentration-dependent effect of melatonin on DSPC membrane
Ipek Sahin a, Duygu Bilge a, Nadide Kazanci a,*, Feride Severcan b
aDepartment of Physics, Faculty of Science, Ege University, 35100 Bornova-Izmir, Turkey bDepartment of Biological Sciences, Middle East Technical University, 06531 Ankara, Turkey Corresponding Author: [email protected] Abstract
The concentration-induced effects of melatonin on distearoyl phosphatidylcholine
(DSPC) model membranes were investigated by using two different non-invasive techniques,
namely Fourier transform infrared (FTIR) spectroscopy and differential scanning calorimetry
(DSC). An investigation of the C-H, C=O and PO2- double bond stretching mode in FTIR
spectra and DSC studies reveals that the inclusion of melatonin changes the physical
properties of the DSPC multilamellar liposomes (MLVs) by shifting the main phase transition
to lower temperatures, abolishing the pretransition, ordering the system in the gel phase and
slightly disordering the system in the liquid crystalline phase, increasing the dynamics both in
the gel phase and liquid crystalline phases. Melatonin also causes strong hydrogen bonding
between C=O and PO2- groups of lipids and the water molecules around.
Keywords: Melatonin; Distearoyl phosphatidylcholine; MLVs; Fourier transform infrared;
Differential scanning calorimetry.
2
1. Introduction
Melatonin (N-acetyl-5-methoxytryptamine), a hormone principally produced and
released by the pineal gland under influence of the environmental light/dark cycle is a
ubiquitously acting direct free radical scavenger [1]. It participates in several important
physiological functions, including detoxifying the devastatingly reactive hydroxyl radical [2],
biologic regulation of circadian rhythms, sleep, mood, reproduction and
neuroimmunomodulation [3]. Moreover, melatonin has also been shown to have diverse other
functions, e.g. influence of immune function as well as antiproliferative and antioxidative
actions [4-7]. It also lowers age-related oxidative damage in the Alzheimer’s disease [8]
Parkinson’s disease [9] and central nervous system [10].
Several mechanisms are combined to explain the protective efficiency of melatonin:
(a) a direct antioxidant action inhibiting the lipid peroxidation, (b) inducing changes on lipidic
bilayers fluidity, (c) protecting intracellular components against peroxidative damage [11].
However, the exact action mechanisms underlying its effect is not well understood and thus
several studies are in progress. One of the mechanisms responsible for the valuable effects of
melatonin could be its membrane action. Despite its potential importance, limited number of
studies are available in the literature about the interaction at molecular level of melatonin with
membranes [11–13]. These electron spin resonance (ESR), fluorescence, differential scanning
calorimetry (DSC), and ultraviolet (UV) studies used rat microsomal membranes and
phosphatidylcholine model membranes in the form of multilamellar, unilamellar, and reversed
micelles. They mainly report the effect of melatonin on membrane dynamics, which are not
always consistent with each other.
Understanding the mechanism of interactions between drugs and cell membranes at
the molecular level has critical importance in a wide variety of scientific disciplines. Many
drugs, displaying a great variety of applications and with various structures, can cross or bind
to lipid membranes and possibly alter the physical properties of that membrane. Biological
membranes are extremely complex supramolecular liquid-crystalline structures principally
composed of phospholipids [14]; thus, in order to better understand the function of melatonin
at molecular level, it is important to study its interaction with membrane components and
specifically with phospholipids. Owing to their structural similarity with biological
membranes, phospholipid liposomes have been used as model membranes for a long time.
Especially, they have been made advantage of investigations of drug/membrane interaction
[15–19].
3
In our previous studies, we investigated the effect of melatonin on lipid phase
transition, lipid order and hydration states of the head group of zwitterionic dipalmitoyl
phosphatidylcholine (DPPC) and dipalmitoyl phosphatidylglycerol (DPPG), in the form of
multilamellar vesicles (MLVs) as a function of temperature and different melatonin
concentrations [20,21]. In the current study, the effect of different concentrations of melatonin
on model membranes composed of another zwitterionic lipid, 1,2-distearoyl-sn-glycero-3-
phosphocholine (DSPC) MLVs, has been investigated by using two different noninvasive
techniques, namely Fourier transform infrared (FTIR) spectroscopy and differential scanning
calorimetry (DSC). These techniques have been widely used in model membrane studies [20,
22,23] and allowed us to obtain detailed information about the concentration dependent
effects of melatonin in two different membrane phases not only on membrane dynamics, but
also on structural parameters, such as lipid phase-transition profile, membrane acyl chain
order, and hydration status of the head group and glycerol backbone regions, which, to the
best of our knowledge, has not been reported previously.
Phospholipids are differentiated from each other by headgroup, chain length, and
unsaturation. It is obvious that the structural differences of the lipids can have important
effects on the drug/membrane interactions. DPPC used in our previous study [20], and DSPC
are both zwitterionic phospholipids with the same polar headgroup and they differ from each
other only in the length of their hydrophobic chain moiety. These phospholipids also are fully
saturated lipids, and they all exhibit many different physical and chemical properties. In this
study, we conducted an intensive investigation on the molecular interactions between
melatonin and lipid by applying liposome as model cell membranes. For this study the
phospholipid distearoyl phosphatidylcholine (DSPC) was considered for liposome
preparations.
2. Materials and methods
Melatonin and DSPC were purchased from Sigma (St.Louis, MO, USA) and used
without further purification. For the infrared measurements, pure phospholipid MLVs were
prepared according to the procedure, reported by Severcan et al. [20]. To prepare DSPC
MLVs, 5 mg of phospholipid was dissolved in chloroform in a round-bottom flask. A dried
lipid film was obtained by evaporating it with a nitrogen flux and then pumping it for at least
2 h under vacuum by using Heto spin vac. The film was hydrated by adding 25 μl of 10 mM
phosphate buffer, pH 7.4. Liposomes were formed by vortexing the mixture at a temperature
4
above the gel-to-fluid phase transition for 20 min. In order to prepare melatonin containing
liposomes, appropriate amount of melatonin was taken from the stock solution, in which
melatonin was dissolved in ethanol, and put in a round-bottom flask. The excess ethanol was
evaporated by nitrogen stream and then 5 mg of phospholipid was added and dissolved in the
same round-bottom flask by chloroform. The same procedure for the preparation of pure
DSPC liposomes was then followed. Sample suspensions of 20 μl were placed between CaF2
windows with the cell thickness of 12 μm. Infrared spectra were obtained using a Spectrum
100 (Perkin-Elmer Inc., Norwalk, CT, USA) equipped with a deuterated triglycine sulfate
(DTGS) detector. The instrument was under continuous dry air purge to eliminate
atmospheric water vapor. Interferograms were averaged for 50 scans at 2 cm-1 resolution.
Temperature was regulated by a Graseby Specac (Kent, UK) digital temperature controller
unit. The samples were incubated for 5 min at each temperature before data acquisition. The
selected temperatures were 40 ºC and 65 ºC for DSPC liposomes. These temperatures
represent the gel phase and the liquid crystalline phase of the lipid membranes, respectively.
Membrane samples were prepared five times and their spectra were collected at the mentioned
temperatures and buffer substraction procedure was performed. Buffer spectra were also
collected at the same temperatures and digitally substracted from the sample spectra collected
at identical conditions. The substraction procedure is performed till the bulk water signal at
2300 cm-1 is flattened. These substracted spectra were used for detailed and statistical
analysis. However, for visual demonstration of the changes, normalized average spectra were
compared [24]. The FTIR spectra were analyzed by using Spectrum v5.0.1 software (Perkin-
Elmer). The vibrational band of CH2 antisymmetric stretching mode was sufficiently
separated after water substraction procedure and therefore no band deconvolution or fit
routines was used to evaluate their bandwidths for relative measurements in this model
membrane study [20,21]. The band positions were evaluated according to the center of
weight, and bandwidth was measured at 0,75x peak height position. Normalization was
applied to the spectra only for visual demonstration of the structural changes by using Perkin
Elmer software. Mann-Whitney U test was applied to determine statistical significance of the
spectral parameters of the drug containing groups in comparison to the pure lipid membrane.
Significant difference was statistically taken into account at the level of P≤0.05. Final results
which were statistically significant were shown by an asterisk on the figures.
The lipid mixture for the DSC measurements were prepared according to the same
procedure as for the infrared study; however, this time, thin films were obtained by hydrating
5
2 mg of phospholipid with 50 μl phosphate buffer. The samples were scanned over a
temperature range of 30–65°C. TA Q 100 DSC (TA Instruments Inc., New Castle, Delaware,
USA) instrument was used with a heating rate of 1 ºC/min [20,24].
3. Results
In the current study DSPC MLVs, both pure and containing different concentrations of
melatonin varied from 1 to 15 mol%, were investigated by FTIR spectroscopy, and DSC. In
the analysis of the FTIR spectra, CH2 antisymmetric, C=O stretching, and PO2- double
stretching bands were studied. The C-H stretching modes at 2800–3000 cm-1, the C=O
stretching mode at 1735 cm-1, and the PO2- double bond stretching mode at 1220–1240 cm-1
were considered.
3.1. DSC Studies Calorimetric investigation of DSPC liposomes with or without melatonin was carried
out in a temperature range of 30–65 ºC. The corresponding heating flow as a function of
temperature curve is shown in Figure 1. The thermogram for pure DSPC liposomes shows
two endothermic peaks corresponding to the pre- and main phase transitions (Tm) occurring at
51.2 and 54.5°C, respectively, which is in agreement with previous studies [25,26]. As seen
from Figure 1, increasing melatonin concentrations eliminates the pretransition peak and
lowers the main phase-transition temperature.
6
Figure 1. DSC curves of DSPC liposomes in the absence and presence of different concentrations of melatonin. 3.2. FTIR Studies FTIR spectroscopy was used to determine the changes in membrane structure and
dynamics by analyzing the wavenumber and bandwidth of different vibrational modes, which
represent the acyl chains, head group, and interfacial region of lipid molecules [20,22,27].
Figure 2a displays the wavenumber variation of the CH2 antisymmetric stretching bands of
DSPC liposomes in the absence and presence of different melatonin concentrations in the gel
phase. Figure 2a gives information also about the order-disorder state (i.e., acyl chain
flexibility) of the membrane [20,24]. The wavenumber of the CH2 stretching bands of acyl
chains depend on the average trans/gauche isomerization in the system, and shifts to higher
wave numbers correspond to an increase in the number of gauche conformers, which implies
a more disordered state [28].
Figure 2. Melatonin concentration dependence of the wavenumber of the CH2 anti symmetric stretching
mode for DSPC liposomes at a) 40 ºC (in the gel phase) b) 65 ºC (in the liquid crystalline phase) (*) P<0.05.
As seen from the Figure 2a, at temperature ranges corresponding to the gel phase (<
Tm), the addition of melatonin results in a decrease in the wavenumber, which indicates an
increase in the number of trans conformers. The increase in the number of trans conformers
implies an increase in the order of the bilayer [23,27-29,]. In contrast, as seen from Figure 2b,
in the liquid crystalline phase (>Tm), the incorporation of different concentrations of
melatonin into the phospholipid system slightly shifts the wavenumber to higher values,
which indicates an increase in the number of gauche conformers. The increase in the number
of gauche conformers implies a decrease in the order of bilayer in liquid crystalline phases
[23,30].
7
Information about the dynamics of membrane systems can be obtained by analyzing
the variations in the bandwidth of the CH2 stretching modes, since bandwidth reflects the
changes in the mobility of the acyl chains. An increase in the bandwidth is an indication of an
increase in the dynamics of the membrane system [24,31-33 ].
Figure 3. Melatonin concentration dependence of the bandwidth of the CH2 anti symmetric stretching mode
for DSPC liposomes at a) 40 ºC (in the gel phase) b) 65 ºC (in the liquid crystalline phase) (*) P<0.05.
Figure 3 shows the bandwidth variation of the CH2 antisymmetric stretching bands of
DSPC MLVs with varying melatonin concentrations in the gel and liquid crystalline phases.
Bandwidth was measured at 0.75x peak height position. Qualitatively similar results were also
obtained at 0.50x peak height position (not shown). It is evident from Figure 3 that the
bandwidth increases with the addition of melatonin both in the gel and liquid crystalline
phases, and thus, melatonin increases the dynamics of the membrane.
In order to examine the interaction of melatonin with glycerol backbone near the head
group of phospholipids in interfacial region, the C=O stretching band was analyzed [20,29].
The wavenumber variation of this band is shown in Figure 4. According to the empirical
rules, a decrease in the wavenumber implies either the strengthening of existing hydrogen
bonding or formation of new hydrogen bonding between the components [20,34]. As seen
from the figures, both in the gel and liquid crystalline phase, the addition of melatonin
produces a decrease in wavenumber, which indicates that melatonin increases hydrogen
bonding around this functional group.
8
Figure 4. Melatonin concentration dependence of the wavenumber of the C=O stretching mode for DSPC
liposomes at a) 40 ºC (in the gel phase) b) 65 ºC (in the liquid crystalline phase) (*) P<0.05.
The interaction between melatonin and head group of DSPC liposomes was monitored
by PO2- double bond stretching mode which is located at 1230 cm-1. Figure 5a and 5b show
variation of the wavenumber of the PO2- double bond stretching mode for DSPC liposomes in
the absence and presence of different concentrations of melatonin in the gel and liquid
crystalline phases, respectively. As seen from the figure, the wavenumber of this band also
shifts to lower values with the addition of different concentrations of melatonin into the DSPC
MLVs, which indicates hydrogen bonding in between phosphate group of DSPC and
melatonin or water molecules [29].
Figure 5. Melatonin concentration dependence of the wavenumber of the PO2- double bond stretching mode for
DSPC liposomes at a) 40 ºC (in the gel phase) b) 65 ºC (in the liquid crystalline phase) (*) P<0.05.
4. Discussion
The interactions between biological cell membranes and drugs at molecular level have
a constitutive effect on the pharmacokinetics of the drugs. They specify partitioning,
9
orientation, and conformation of the drugs in the membranes and hence play an important role
in transport, distribution, accumulation, and finally efficacy of the drugs [35-37]. These
interactions can also alter the physicochemical properties and thus the functioning of the
membranes. Melatonin is one of the most important molecule among the endogenous
molecules that could change membrane properties, because it penetrates all physiologic
barriers [11,38,39]. Moreover, melatonin and its metabolites have antioxidant properties that
prevent damage induced by reactive species through several mechanisms, principally as a
scavenger of these oxidative agents [40–46].
Interaction of melatonin with DPPC and DPPG MLVs has been studied in detail,
previously by our group, as a function of temperature and melatonin concentrations [20,21].
In the current study, we investigated the effect of melatonin on lipid phase transition, lipid
order, and hydration states of the head group of DSPC as a function of melatonin
concentrations varying from 1 to 15 mol%. In this study two non-perturbing techniques,
namely Fourier transform infrared (FTIR) spectroscopy and differential scanning calorimetry
(DSC) were used. DSC is a thermodynamic technique convenient for studying phase
transitions of membrane bilayers with and without inserted drug molecules. It has been widely
used to investigate the thermal changes caused by the incorporation of the drugs into the
membrane bilayers. FTIR spectroscopy is based on monitoring the energy absorbed between
vibrational energy levels of different functional groups belonging to macromolecules in
biological systems. For this reason, it gives a spectrum unique to the system where the bands
assigned to different functional groups can be monitored simultaneously. The change in the
frequencies of the infrared bands in the membrane, owing to drug administration, bring out
relative structural information, such as lipid acyl chain flexibility and nature of the chemical
bonds. In the present study, in the interpretation of the results of FTIR spectra, we were
particularly careful in distinguishing between structural parameters describing molecular
order and motion parameters such as bandwidth describing molecular dynamics as suggested
by others [47]. We investigated effects of melatonin on hydrophilic portion of the membrane
by analyzing C = O stretching band and PO2- double bond stretching mode on hydrophobic
portion of the membrane by analyzing C-H stretching region.
The most largely studied phospholipids are the phosphatidylcholines (PCs) [48,49]
due to their widespread inclusion in cell membranes as a structural component. They are
major components of biological membranes and other biological lipid-containing structures
and fluids. The PCs are generally the major zwitterionic phospholipid classes, and found in
eucaryotic plasma membranes. For example, a saturated diacyl phosphatidylcholine, DPPC
10
used in our previous study [20], is the major component of pulmonary surfactant, where it
exists as amonolayer and undergoes rapid changes from liquid-expanded to liquid-condensed
states with each respiratory cycle. The PCs with different hydrocarbon chain length (e.g., C16
and C18) are of different surface properties and exhibit an increase in the cooperativity of their
phase transition as a function of chain length. Each has its effect on the properties of the
membrane. Saturated PCs, especially DPPC and DSPC, are frequently incorporated into
liposomes to be used as model membranes and as potential drug delivery systems. DSPC used
in this study belongs to a family of saturated, symmetric, dialkylphosphocholines (PCs)
having alkyl chain lengths of 18 carbon atoms (distearoyl-PC or DSPC) . In this study we
aimed to contribute to a more thorough understanding of the effect of melatonin on the major
components of biological lipid assemblies by systematically investigating the interaction of
melatonin with model lipid assemblies composed of phosphatidylcholine. We have extended
our previous investigations [20,21] to the interactions of melatonin with DSPC which has
different chain length as compared with DPPC.
Our DSC and FTIR data reveal that melatonin eliminates the pretransition temperature
and shifts the main phase-transition temperature (Tm) of DSPC membranes gradually to lower
temperatures as drug concentration is increased. Previously Saija et al. [11], Severcan et al.
[20] and Sahin et al. [21] also reported a decrease in Tm in the presence of melatonin for
DMPC, DPPC and DPPG MLVs respectively, which have shorter acyl chains than that of
DSPC.
The analysis of the wavenumber of the CH2 antisymmetric stretching mode in FTIR
spectra showed that melatonin decreases acyl chain flexibility, i.e., increases order of DSPC
membranes in the gel phase and slightly decreases in the liquid crystalline phase (Fig. 2a and
2b). The same result in the gel phase was observed in our previous study where we
investigated interactions of melatonin with DPPC MLVs [20]. The increase in the order
means an increase in the number of trans conformers on the acyl chains of membrane which
indicates an increase in the thickness of the membrane.
The bandwidth of the CH2 symmetric and antisymmetric stretching bands gives
information about lipid fluidity in membranes [20,22,24,31,32]. The results of this analysis
revealed that melatonin increases the fluidity of pure DSPC membranes at all concentrations.
The fluidity is expected to influence bilayer permeability property, which is required for
normal and optimal activity of membrane associated structures. There are limited number of
studies in the literature about the effect of melatonin on membrane dynamics whose results
were not always consistent with each other [11,13,20,50,51]. For example, Drolle et al. used
11
small-angle neutron diffraction (SAND) from oriented lipid multi-layers, small-angle neutron
scattering (SANS) from unilamellar vesicles experiments and Molecular Dynamics (MD)
simulations to elucidate non-specific interactions of melatonin and cholesterol with 1,2-
dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-dipalmitoyl-snglycero-3-
phosphocholine (DPPC) model membranes and they concluded that melatonin decreases the
thickness of both model membranes by disordering the lipid hydrocarbon chains, thus
increasing membrane fluidity [51]. Another study using DSC technique, also reported a
significant fluidizing effect of melatonin on dimyristoylphosphotidylcholine (DMPC) MLVs
and LUVs, at concentrations of melatonin varied from 1.5 to 18 mol% [11]. These results are
in agreement with our previous DPPC MLVs study [20] and with our present study.
Conflicting these studies including ours, Costa et al. reported a decrease in membrane
dynamics with the addition of melatonin in DMPC [13]. It is wellknown that melatonin is a
powerful endogenous antioxidative molecule protecting cells from oxidative damage and it
has strong anti lipid peroxidation properties [52-55]. It is also known that there is a strong
relevance between lipid peroxidation and fluidity of cell membranes [56,57]. As reported
previously, lipid peroxidation stress decreases membrane fluidity in cellular membranes [58-
60]. In addition to its antioxidative protection, the biophysical effects of melatonin on the
membrane may also contribute to its cell protective properties. The influence of melatonin on
membrane fluidity could be connected with possible mechanism for the observed reduction in
membrane damage. Melatonin’s fluidifying effect may thus reduce the effect of lipid
peroxidation on the membrane dynamics [61-63].
In the present study, melatonin showed an increase in the hydrogen bonding of C=O
and PO2- groups in both the gel and liquid crystalline phases. The electronegative atom is the
nitrogen of the furanose ring of melatonin, which has a partial negative charge. The hydrogen
in the N–H group in this ring has a partial positive charge. This hydrogen can make hydrogen
bonding with the oxygen atoms in the C=O and PO2- functional groups of the lipids. The
possibility of melatonin-induced hydrogen bonding between the oxygen molecules of both
carbonyl and phosphate groups of DSPC and nearby water molecules should also be
considered. In another study wherein interaction of melatonin with DMPC model membrane
was analyzed by UV spectroscopy, Ceraulo et al. reported that melatonin strongly interacts
with polar head region of the membrane and forms strong hydrogen bonds [12]. These results
are consistent with our previous studies where we investigated the interactions of melatonin
with DPPC and DPPG MLVs [20,21].
12
The strong hydrogen bonding induced by melatonin at the carbonyl and phosphate
groups in DSPC membranes (Figs. 4 and 5) and the lack of broadening in the phase transition
curve (Fig. 1) suggests that melatonin does not perturb entirely the cooperativity region (C2–
C8) of the acyl chains and melatonin molecule positions itself in the bilayer with a preferential
location in the interfacial region [20,64]. Since melatonin is a small amphiphilic molecule, it
is soluble both in fats and in water [65,66], preferably located at hydrophilic/hydrophobic
interfaces and can readily cross all the anatomic barriers. These specifications make melatonin
able to protect all the cellular structures from oxidant agents.
In conclusion, we found melatonin, when incorporated in the lipid bilayers, to interact
actively with the lipids and to induce changes in their physico-chemical properties. In
addition, a possible location of melatonin in the interfacial region of the membrane has been
proposed. The data presented here clarify, to a certain extent, the molecular interactions of
melatonin with membrane systems and may additionally contribute to a better understanding
of melatonin’s physiologic properties and the development of therapeutic advanced systems.
13
References [1] R.J. Reiter, D.X. Tan, M.P. Terron, L.J. Flores, Z. Czarnocki, Acta Biochim. Pol. 54 (2007) 1. [2] D.X. Tan, L.D. Chen, B. Poeggeler, L.C. Manchester, R.J. Reiter, Endocr. J. 1 (1993) 57. [3] C.R.T. Vijayalaxmi, R.J. Reiter, T.S. Herman, J. Clin Oncol. 20 (2002) 2575. [4] C.E. Beyer, J.D. Steketee, D. Saphier, Biochem. Pharmacol. 56 (1998) 1265. [5] M. Allegra, R.J. Reiter, D.X. Tan, C. Gentile, L. Tesoriere, M.A. Livrea, J. Pineal Res. 34 (2003) 1. [6] F. Ercan, S. Cetinel, G. Contuk, E. Cikler, G. Sener, J. Pineal Res. 37 (2004) 113. [7] D.X. Tan, L.C. Manchester, M.P. Terron, L.J. Flores, R.J.R.J. Reiter, J. Pineal Res. 42 (2007) 28. [8] M.A. Pappolla, M. Sos, R.A. Omar, R.J. Bick, D.L. Hickson-Bick, R.J. Reiter, S. Efthimiopoulos, N.K. Robakis, J. Neurosci. 17 (1997) 1683. [9] G. Rocchitta, R. Migheli, G. Esposito, B. Marchetti, M.S. Desole, E. Miele, P.A. Serra, J. Pineal Res. 40 (2006) 204. [10] R.J. Reiter, D.X. Tan, B. Poeggeler, A. Menendez-Pelaez, L.D. Chen, S. Saarela, Ann. NY. Acad. Sci. 719 (1994) 1. [11] A. Saija, A. Tomaino, D. Trombetta, M.L. Pellegrino, B. Tita, S. Caruso, F. Castelli, Eur. J. Pharm. Biopharm. 53 (2002) 209. [12] L. Ceraulo, M. Ferrugia, L. Tesoriere, S. Segreto, M.A. Livrea, T. Liveri, J. Pineal Res. 26 (1999) 108. [13] E.J.X. Costa, C.S. Shida, M.H. Biaggi, A.S. Ito, M.T. Lamy-Freund, FEBS Lett. 416 (1997) 103. [14] K.M. Merz, Jr., B. Roux (Eds), Biological membranes:A molecular perspective from computation and experiment, Birkhauser, Boston, 1996, (Chapter 1). [15] A. Avdeef, K.J. Box, J.E.A. Comer, C. Hibbert, K.Y. Tam, Pharm. Res. 15 (1998) 209. [16] F. Beigi, Q. Yang, P. Lundahl, J. Chromatogr. A 704 (1995) 315.
14
[17] G.P. van Balen, C.M. Martinet, G. Caron, G. Bouchard, M. Reist, P.A. Carrupt, R. Fruttero, A. Gasco, B. Testa, Med. Res. Rev. 24 (2004) 299. [18] F. Zhang, E.S. Rowe, Biochemistry 31 (1992) 2005. [19] Y.X. Zhang, R. Zhang, S. Hjerten, P. Lundahl, Electrophoresis 16 (1995) 1519. [20] F. Severcan, I. Sahin, N. Kazancı, Biochim. Biophys. Acta 1668 (2005) 215. [21] I. Sahin, F. Severcan, N. Kazancı, J. Mol. Struct. 834/836 (2007) 195. [22] B. Biruss, R. Dietl, C. Valenta, Chem. Phys. Lipids 148 (2007) 84. [23] J. Villalain, F.J. Aranda, J.C. Gomezfernandez, Eur. J. Biochem. 158 (1986) 141. [24] F. Korkmaz, F. Severcan, Arch. Biochem. Biophys. 440 (2005) 141. [25] F. Szoka, D. Papahadjopoulos, Annu. Rev. Biophys. Bioeng. 9 (1980) 467. [26] N. Tamai, M. Uemura, T. Takeichi, M. Goto, H. Matsuki, S. Kaneshina, Biophys. Chem. 135 (2008) 95. [27] H.L. Casal, H.H. Mantsch, Biochim. Biophys. Acta 779 (1984) 381. [28] F. Severcan, Biosci. Rep. 17 (1997) 231. [29] N. Toyran, F. Severcan, Chem. Phys. Lipids 123 (2003) 165. [30] N. Kazancı, N. Toyran, P.I. Haris, F. Severcan, Spectroscopy 15 (2001) 47–55. [31] H.L. Casal, D.G. Cameron, I.C.P. Smith, H.H. Mantsch, Biochemistry 19 (1980) 444. [32] F. Lopezgarcia, V. Micol, J. Villalain, J.C. Gomezfernandez, Biochim. Biophys. Acta 1169 (1993) 264. [33] F. Severcan, N. Kazanci, F. Zorlu, Biosci. Rep. 20 (2000) 177. [34] U.P. Frengeli, H.H. Gu¨nthard, Biochim. Biophys. Acta 450 (1976) 101–106. [35] K.S. Joachim, E.A. Coats, H.P. Cordes, M. Wiese, Arch. Pharm. 327 (1994) 601. [36] K.S. Joachim, A. Velasco, E.A. Coats, H.P. Cordes, B. Kunz, M. Wiese, Quant. Struct. Act. Relat. 11 (1992) 205. [37] J.K. Seydel, M. Wiese, in M. Raimund, H. Kubinyi, G. Folkers (Eds), Drug–Membrane Interactions, vol. 15, Wiley-VCH Verlag GmbH, Weinheim, 2002. [38] M.W. De Vries, F.P. Peeters, J. Pineal. Res. 185 (1997) 201.
15
[39] D. Bongiorno, L. Ceraulo, M. Ferrugia, F. Filizzola, A. Ruggirello, V.T. Liveri, J. Pineal. Res. 38 (2005) 292. [40] R.J. Reiter, News Physiol. Sci. 15 (2000) 246. [41] A. Teixeira, M.P. Morfim, C.A.S. De Cordova, C.C.T. Charao, V.R. De Lima, T.B. Creczynski-Pasa, J. Pineal. Res. 35 (2003) 262. [42] J. Rosen, N.N. Than, D. KoCh, B. Poeggeler, H. Laatsch, R. Hardeland, J. Pineal. Res. 41 (2006) 374. [43] D.X. Tan, L.C. Manchester, M.P. Terron, L.J. Flores, R.J. Reiter, J. Pineal. Res. 42 (2007) 28. [44] R. Hardeland, S.R. Pandi-Perumal, D.P. Cardinali, Int. J. Biochem. Cell Biol. 38 (2006) 313. [45] F. Peyrot, C. Ducrocq, J. Pineal. Res. 45 (2008) 235. [46] R. Hardeland, D.X. Tan, R.J. Reiter, J. Pineal. Res. 47 (2009) 109. [47] G.V. Ginkel, H.V. Langen, Y.K. Levine, Biochimie 71 (1989) 23. [48] M. Caffrey, LIPIDAT: A database of thermodynamic data and associated information on lipid mesomorphic and polymorphic transitions, CRC Press, Boca Raton, 1993. [49] M. Caffrey, J. Hogan, Chem. Phys. Lipids 61 (1992) 1. [50] J.J. Garcia, R.J. Reiter, J.M. Guerrero, G. Escames, B.P. Yu, C.S. Oh, A. Munoz-Hoyos, FEBS Lett. 408 (1997) 297. [51] E. Drolle, N. Kucerka, M.I. Hoopes, Y. Choi, J. Katsaras, M. Karttunen, Z. Leonenko, BBA-Biomembranes 1828 (2013) 2247. [52] R.J. Reiter, D.X. Tan, J.C. Mayo, R.M. Sainz, J. Leon, Z. Czarnocki, Acta Biochim. Pol. 50 (2003) 1129. [53] G. Anderson, M. Maes, M. Berk, Prog. Neuro-Psychoph. 42 (2013) 101. [54] M.B. Arnao, J.H. Ruiz, Food Chem. 138 (2013) 1212. [55] V. Srinivasan, C. Kaur, S.P. Perumal, G.M. Brown, D.P. Cardinali, Int. J. Alzheimers Dis. 2011 (2011) 1. [56] E. Niki, Free Radic. Biol. Med. 47 (2009) 469. [57] A. Watanabe, N. Noguchi, A. Fujisawa, T. Kodama, K. Tamura, O. Cynshi, E. Niki, J. Am. Chem. Soc. 123 (2000) 5438. [58] P. Kaplan, P. Racay, J. Lehotsky, V. Mezesova, Neurochem. Res. 20 (1995) 815.
16
[59] H. Watanabe, A. Kobayashi, T. Yamamoto, S. Suzuki, H. Hayashi, N. Yamazaki, Free Radic. Biol. Med. 9 (1990) 507. [60] C. Ghosh, R.M. Dick, S.F. Ali, Neurochem. Int. 23 (1993) 479. [61] G. Bekyarova, B. Galunska, D. Ivanova, T. Yankova, Burns 35 (2009) 863. [62] D.S. Sheth, N.F. Tajuddin, M.J. Drusea, Brain Res. 1285 (2009) 14. [63] H. Shilian, Y. Shi, J. Xiaodong, H. Dabing, S. Gan, Eur. J. Pharmacol. 616 (2009) 287. [64] M.K. Jain, N. Min Wu, J. Membr. Biol. 34 (1977) 157. [65] R.J. Reiter, Endocrine Rev. 12 (1991) 151. [66] C.S. Shida, A.M.L. Castrucci, M.T.J. Lamy-Freund, Pineal Res. 16 (1994) 198.
17
18
19
20
21
22
Highlights:
►The interaction of melatonin on DSPC MLVs was investigated.
►Spectral and calorimetric analysis techniques were used in this study.
►This study shows there are strong interactions between melatonin and lipid membranes.
23